HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. Announce Potential Acquisition and Financing Agreements for 30 Million in Currently-Operating Interventional Psychiatry Clinics
| NRXP Stock | USD 1.26 0.09 6.67% |
Slightly above 61% of NRX Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding NRX Pharmaceuticals suggests that many traders are alarmed. NRX Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in NRX Pharmaceuticals. Many technical investors use NRX Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
NRX |
HOPE Therapeutics, Inc., a wholly-owned subsidiary of NRx Pharmaceuticals, Inc. , a medical and technology driven company, today announced signing a non-binding Term Sheet for non-dilutive, nonconvertible debt acquisition funding of its first interventional psychiatry clinics , together with the signing of a Term Sheet for five currently operational clinics in the Western United States. In addition to the currently-signed non-bi
Read at finance.yahoo.com
 |
NRX Pharmaceuticals Fundamental Analysis
We analyze NRX Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NRX Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NRX Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
NRX Pharmaceuticals is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
NRX Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NRX Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of NRX Pharmaceuticals could also be used in its relative valuation, which is a method of valuing NRX Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
NRX Pharmaceuticals Related Equities
| QNRX | Quoin Pharmaceuticals | 28.12 | ||||
| LEXX | Lexaria Bioscience | 20.54 | ||||
| RNXT | RenovoRx | 5.83 | ||||
| LGVN | Longeveron LLC | 2.43 | ||||
| ADTX | Aditxt | 2.70 | ||||
| CING | Cingulate | 3.02 | ||||
| VRAX | Virax Biolabs | 4.62 | ||||
| NTRB | Nutriband | 9.01 | ||||
| PHGE | Biomx | 13.70 | ||||
| SNTI | Senti Biosciences | 28.60 |
Additional Tools for NRX Stock Analysis
When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.